October 15th, 2012
Selections from Richard Lehman’s Literature Review: October 15th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include PCI use in states with public reporting of outcomes; proneurotensin as a prognostic marker for CVD, diabetes, and mortality; vorapaxar for secondary prevention of thrombotic events in patients with previous MI; and atenolol vs. metoprolol for hypertension.
October 12th, 2012
PCI Public Reporting Programs: Incentivizing Better Decisions?
Joseph S. Ross, MD, MHS
Joe Ross wonders what’s really behind the lower rates of PCI use in states that have public reporting programs.
NEJM Journal Watch — Recent Cardiology Articles- Persistent Symptoms After Valve Replacement for Severe Aortic Stenosis
- Is Diltiazem Safe in Patients with AF Taking Apixaban or Rivaroxaban?
- Does Lowering High Childhood Lipid Levels Prevent Adverse Cardiovascular Events in Adulthood?
- Self-Expanding Supraannular Valve vs. Balloon-Expandable Valve in TAVR for Small Aortic Annulus
- A New TAVR Prosthesis for Aortic Regurgitation Shows Promise